588 related articles for article (PubMed ID: 26681674)
21. Using circulating cell-free DNA to monitor personalized cancer therapy.
Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
[TBL] [Abstract][Full Text] [Related]
22. Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia.
Hata T; Suenaga M; Marchionni L; Macgregor-Das A; Yu J; Shindo K; Tamura K; Hruban RH; Goggins M
Am J Pathol; 2018 Jul; 188(7):1723-1733. PubMed ID: 29684357
[TBL] [Abstract][Full Text] [Related]
23. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Ma X; Liu Y; Liu Y; Alexandrov LB; Edmonson MN; Gawad C; Zhou X; Li Y; Rusch MC; Easton J; Huether R; Gonzalez-Pena V; Wilkinson MR; Hermida LC; Davis S; Sioson E; Pounds S; Cao X; Ries RE; Wang Z; Chen X; Dong L; Diskin SJ; Smith MA; Guidry Auvil JM; Meltzer PS; Lau CC; Perlman EJ; Maris JM; Meshinchi S; Hunger SP; Gerhard DS; Zhang J
Nature; 2018 Mar; 555(7696):371-376. PubMed ID: 29489755
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.
Hayashi H; Tanishima S; Fujii K; Mori R; Okada C; Yanagita E; Shibata Y; Matsuoka R; Amano T; Yamada T; Yabe I; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Cancer Sci; 2020 Oct; 111(10):3926-3937. PubMed ID: 32772458
[TBL] [Abstract][Full Text] [Related]
25. Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array.
Di Marco M; Astolfi A; Grassi E; Vecchiarelli S; Macchini M; Indio V; Casadei R; Ricci C; D'Ambra M; Taffurelli G; Serra C; Ercolani G; Santini D; D'Errico A; Pinna AD; Minni F; Durante S; Martella LR; Biasco G
Mol Med Rep; 2015 Nov; 12(5):7479-84. PubMed ID: 26397140
[TBL] [Abstract][Full Text] [Related]
26. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
Ho J; Li X; Zhang L; Liang Y; Hu W; Yau JCW; Chan H; Gin T; Chan MTV; Tse G; Wu WKK
Semin Cancer Biol; 2019 Apr; 55():70-77. PubMed ID: 29705685
[TBL] [Abstract][Full Text] [Related]
27. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
28. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
[TBL] [Abstract][Full Text] [Related]
29. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
30. Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Rantalainen M; Klevebring D; Lindberg J; Ivansson E; Rosin G; Kis L; Celebioglu F; Fredriksson I; Czene K; Frisell J; Hartman J; Bergh J; Grönberg H
Sci Rep; 2016 Nov; 6():38037. PubMed ID: 27901097
[TBL] [Abstract][Full Text] [Related]
31. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
[TBL] [Abstract][Full Text] [Related]
32. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
33. Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.
Saldivar JS; Harris J; Ayash E; Hong M; Tandon P; Sinha S; Hebron PM; Houghton EE; Thorne K; Goodman LJ; Li C; Marfatia TR; Anderson J; Morra M; Lyle J; Bartha G; Chen R
Oncotarget; 2023 Aug; 14():789-806. PubMed ID: 37646774
[TBL] [Abstract][Full Text] [Related]
34. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract][Full Text] [Related]
35. Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.
Zill OA; Greene C; Sebisanovic D; Siew LM; Leng J; Vu M; Hendifar AE; Wang Z; Atreya CE; Kelley RK; Van Loon K; Ko AH; Tempero MA; Bivona TG; Munster PN; Talasaz A; Collisson EA
Cancer Discov; 2015 Oct; 5(10):1040-8. PubMed ID: 26109333
[TBL] [Abstract][Full Text] [Related]
36. Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis.
Grassi E; Durante S; Astolfi A; Tarantino G; Indio V; Freier E; Vecchiarelli S; Ricci C; Casadei R; Formica F; Filippini D; Comito F; Serra C; Santini D; D' Errico A; Minni F; Biasco G; Di Marco M
Int J Oncol; 2018 Jun; 52(6):1972-1980. PubMed ID: 29620163
[TBL] [Abstract][Full Text] [Related]
37. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
39. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
40. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
